Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.04)
# 606
Out of 4,479 analysts
397
Total ratings
46.52%
Success rate
11.97%
Average return
Main Sectors:
52 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIGL Vigil Neuroscience | Reiterates: Buy | $24 | $4.37 | +449.20% | 7 | Jun 28, 2024 | |
| SVRA Savara | Maintains: Buy | $6 → $10 | $4.64 | +115.52% | 7 | Jun 27, 2024 | |
| SYRS Syros Pharmaceuticals | Reiterates: Buy | $15 | $4.93 | +204.26% | 11 | Jun 26, 2024 | |
| AMLX Amylyx Pharmaceuticals | Reiterates: Buy | $8 | $1.88 | +325.53% | 14 | Jun 24, 2024 | |
| ALEC Alector | Reiterates: Buy | $35 | $4.42 | +691.86% | 7 | Jun 20, 2024 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Buy | $40 → $20 | $4.19 | +377.33% | 13 | Jun 18, 2024 | |
| KROS Keros Therapeutics | Reiterates: Buy | $100 | $43.77 | +128.47% | 9 | Jun 18, 2024 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $46 | $30.95 | +48.63% | 6 | Jun 17, 2024 | |
| ANNX Annexon | Reiterates: Buy | $30 | $5.05 | +494.06% | 11 | Jun 4, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $15 | $5.93 | +152.95% | 9 | Jun 4, 2024 | |
| CPRX Catalyst Pharmaceuticals | Reiterates: Buy | $26 | $15.77 | +64.87% | 10 | Jun 3, 2024 | |
| MRUS Merus | Maintains: Buy | $65 → $85 | $54.45 | +56.11% | 12 | May 29, 2024 | |
| INSM Insmed | Maintains: Buy | $52 → $70 | $66.34 | +5.52% | 6 | May 29, 2024 | |
| BIIB Biogen | Reiterates: Buy | $300 | $231.77 | +29.44% | 14 | May 23, 2024 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $48 | $35.49 | +35.25% | 4 | May 20, 2024 | |
| ARVN Arvinas | Reiterates: Buy | $87 | $25.98 | +234.87% | 11 | May 17, 2024 | |
| PEPG PepGen | Reiterates: Buy | $26 | $17.91 | +45.17% | 7 | May 15, 2024 | |
| UBX Unity Biotechnology | Reiterates: Buy | $8 | $1.33 | +501.50% | 6 | May 15, 2024 | |
| LQDA Liquidia | Reiterates: Buy | $32 | $12.04 | +165.78% | 6 | May 15, 2024 | |
| ABOS Acumen Pharmaceuticals | Reiterates: Buy | $15 | $2.39 | +528.93% | 7 | May 15, 2024 | |
| STRO Sutro Biopharma | Reiterates: Buy | $12 | $3.05 | +293.44% | 9 | May 14, 2024 | |
| FULC Fulcrum Therapeutics | Reiterates: Buy | $17 | $6.31 | +169.41% | 11 | May 14, 2024 | |
| PRQR ProQR Therapeutics | Reiterates: Buy | $5 | $1.65 | +203.03% | 8 | May 10, 2024 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $33 → $27 | $16.04 | +68.33% | 14 | May 9, 2024 | |
| PRTA Prothena Corporation | Maintains: Buy | $90 → $84 | $20.48 | +310.16% | 10 | May 9, 2024 | |
| KMDA Kamada | Reiterates: Buy | $11 | $4.83 | +127.74% | 6 | May 9, 2024 | |
| DBVT DBV Technologies | Maintains: Buy | $20 → $10 | $0.82 | +1,121.60% | 9 | May 8, 2024 | |
| DNLI Denali Therapeutics | Reiterates: Buy | $95 | $22.01 | +331.62% | 11 | May 8, 2024 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $35 | $13.87 | +152.34% | 8 | May 7, 2024 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $462 | $471.25 | -1.96% | 16 | May 7, 2024 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $20 | $5.84 | +242.47% | 11 | May 7, 2024 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $30 | $6.67 | +349.78% | 5 | May 7, 2024 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $2.09 | +1,000.48% | 10 | May 6, 2024 | |
| BPMC Blueprint Medicines | Maintains: Buy | $125 → $135 | $109.18 | +23.65% | 12 | May 3, 2024 | |
| KALV KalVista Pharmaceuticals | Maintains: Buy | $24 → $20 | $11.89 | +68.21% | 9 | May 3, 2024 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $150 → $160 | $140.11 | +14.20% | 8 | May 2, 2024 | |
| UTHR United Therapeutics | Reiterates: Buy | $300 | $319.01 | -5.96% | 8 | May 2, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $18 → $8 | $1.62 | +393.83% | 8 | Mar 18, 2024 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $3.98 | +302.01% | 9 | Mar 15, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $8 → $15 | $5.24 | +186.53% | 5 | Mar 7, 2024 | |
| CCCC C4 Therapeutics | Maintains: Buy | $17 → $7 | $4.85 | +44.33% | 6 | Nov 2, 2023 | |
| PULM Pulmatrix | Reiterates: Buy | $10 | $1.96 | +410.20% | 5 | Aug 15, 2023 | |
| BLPH Bellerophon Therapeutics | Maintains: Buy | $30 → $2 | $0.06 | +3,471.43% | 4 | Jun 6, 2023 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $3 | $49.40 | -93.93% | 2 | Mar 8, 2023 | |
| MEIP MEI Pharma | Maintains: Buy | $100 → $40 | $2.85 | +1,303.51% | 2 | Feb 13, 2023 | |
| MTNB Matinas BioPharma Holdings | Reiterates: Buy | $3 | $0.16 | +1,766.83% | 1 | Jan 31, 2023 | |
| ELOX Eloxx Pharmaceuticals | Maintains: Neutral | $40 → $20 | $0.70 | +2,757.14% | 4 | May 9, 2022 | |
| AMRN Amarin Corporation | Downgrades: Neutral | $10 → $3 | $0.69 | +337.32% | 1 | May 5, 2022 | |
| ALDX Aldeyra Therapeutics | Assumes: Buy | $15 | $3.25 | +361.54% | 1 | Apr 27, 2022 | |
| APRE Aprea Therapeutics | Maintains: Neutral | $80 → $40 | $4.03 | +892.56% | 3 | Mar 16, 2022 | |
| OCUP Ocuphire Pharma | Initiates: Buy | n/a | $1.59 | - | 1 | Nov 24, 2021 | |
| TBIO Telesis Bio | Maintains: Buy | $576 → $504 | $3.86 | +12,956.99% | 3 | Mar 18, 2021 |
Vigil Neuroscience
Jun 28, 2024
Reiterates: Buy
Price Target: $24
Current: $4.37
Upside: +449.20%
Savara
Jun 27, 2024
Maintains: Buy
Price Target: $6 → $10
Current: $4.64
Upside: +115.52%
Syros Pharmaceuticals
Jun 26, 2024
Reiterates: Buy
Price Target: $15
Current: $4.93
Upside: +204.26%
Amylyx Pharmaceuticals
Jun 24, 2024
Reiterates: Buy
Price Target: $8
Current: $1.88
Upside: +325.53%
Alector
Jun 20, 2024
Reiterates: Buy
Price Target: $35
Current: $4.42
Upside: +691.86%
Zentalis Pharmaceuticals
Jun 18, 2024
Maintains: Buy
Price Target: $40 → $20
Current: $4.19
Upside: +377.33%
Keros Therapeutics
Jun 18, 2024
Reiterates: Buy
Price Target: $100
Current: $43.77
Upside: +128.47%
Kymera Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $30.95
Upside: +48.63%
Annexon
Jun 4, 2024
Reiterates: Buy
Price Target: $30
Current: $5.05
Upside: +494.06%
TScan Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $15
Current: $5.93
Upside: +152.95%
Catalyst Pharmaceuticals
Jun 3, 2024
Reiterates: Buy
Price Target: $26
Current: $15.77
Upside: +64.87%
Merus
May 29, 2024
Maintains: Buy
Price Target: $65 → $85
Current: $54.45
Upside: +56.11%
Insmed
May 29, 2024
Maintains: Buy
Price Target: $52 → $70
Current: $66.34
Upside: +5.52%
Biogen
May 23, 2024
Reiterates: Buy
Price Target: $300
Current: $231.77
Upside: +29.44%
Dyne Therapeutics
May 20, 2024
Maintains: Buy
Price Target: $46 → $48
Current: $35.49
Upside: +35.25%
Arvinas
May 17, 2024
Reiterates: Buy
Price Target: $87
Current: $25.98
Upside: +234.87%
PepGen
May 15, 2024
Reiterates: Buy
Price Target: $26
Current: $17.91
Upside: +45.17%
Unity Biotechnology
May 15, 2024
Reiterates: Buy
Price Target: $8
Current: $1.33
Upside: +501.50%
Liquidia
May 15, 2024
Reiterates: Buy
Price Target: $32
Current: $12.04
Upside: +165.78%
Acumen Pharmaceuticals
May 15, 2024
Reiterates: Buy
Price Target: $15
Current: $2.39
Upside: +528.93%
Sutro Biopharma
May 14, 2024
Reiterates: Buy
Price Target: $12
Current: $3.05
Upside: +293.44%
Fulcrum Therapeutics
May 14, 2024
Reiterates: Buy
Price Target: $17
Current: $6.31
Upside: +169.41%
ProQR Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $5
Current: $1.65
Upside: +203.03%
ACADIA Pharmaceuticals
May 9, 2024
Maintains: Buy
Price Target: $33 → $27
Current: $16.04
Upside: +68.33%
Prothena Corporation
May 9, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $20.48
Upside: +310.16%
Kamada
May 9, 2024
Reiterates: Buy
Price Target: $11
Current: $4.83
Upside: +127.74%
DBV Technologies
May 8, 2024
Maintains: Buy
Price Target: $20 → $10
Current: $0.82
Upside: +1,121.60%
Denali Therapeutics
May 8, 2024
Reiterates: Buy
Price Target: $95
Current: $22.01
Upside: +331.62%
Stoke Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $35
Current: $13.87
Upside: +152.34%
Vertex Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $462
Current: $471.25
Upside: -1.96%
Foghorn Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $20
Current: $5.84
Upside: +242.47%
BioCryst Pharmaceuticals
May 7, 2024
Reiterates: Buy
Price Target: $30
Current: $6.67
Upside: +349.78%
Protara Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $23
Current: $2.09
Upside: +1,000.48%
Blueprint Medicines
May 3, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $109.18
Upside: +23.65%
KalVista Pharmaceuticals
May 3, 2024
Maintains: Buy
Price Target: $24 → $20
Current: $11.89
Upside: +68.21%
Neurocrine Biosciences
May 2, 2024
Maintains: Buy
Price Target: $150 → $160
Current: $140.11
Upside: +14.20%
United Therapeutics
May 2, 2024
Reiterates: Buy
Price Target: $300
Current: $319.01
Upside: -5.96%
I-Mab
Mar 18, 2024
Reiterates: Buy
Price Target: $18 → $8
Current: $1.62
Upside: +393.83%
AC Immune
Mar 15, 2024
Reiterates: Buy
Price Target: $16
Current: $3.98
Upside: +302.01%
Wave Life Sciences
Mar 7, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $5.24
Upside: +186.53%
C4 Therapeutics
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $4.85
Upside: +44.33%
Pulmatrix
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $1.96
Upside: +410.20%
Bellerophon Therapeutics
Jun 6, 2023
Maintains: Buy
Price Target: $30 → $2
Current: $0.06
Upside: +3,471.43%
Corbus Pharmaceuticals Holdings
Mar 8, 2023
Reiterates: Buy
Price Target: $3
Current: $49.40
Upside: -93.93%
MEI Pharma
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.85
Upside: +1,303.51%
Matinas BioPharma Holdings
Jan 31, 2023
Reiterates: Buy
Price Target: $3
Current: $0.16
Upside: +1,766.83%
Eloxx Pharmaceuticals
May 9, 2022
Maintains: Neutral
Price Target: $40 → $20
Current: $0.70
Upside: +2,757.14%
Amarin Corporation
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.69
Upside: +337.32%
Aldeyra Therapeutics
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $3.25
Upside: +361.54%
Aprea Therapeutics
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $4.03
Upside: +892.56%
Ocuphire Pharma
Nov 24, 2021
Initiates: Buy
Price Target: n/a
Current: $1.59
Upside: -
Telesis Bio
Mar 18, 2021
Maintains: Buy
Price Target: $576 → $504
Current: $3.86
Upside: +12,956.99%